Navigation Links
Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin

VIENNA, Va., June 20, 2007 /PRNewswire/ -- Modigene Inc., a Nevada corporation today announced the successful completion of pharmacokinetic and pharmacodynamic pre-clinical experiments for long-acting human growth hormone, long-acting interferon beta and long-acting erythropoietin.

Modigene's pharmacodynamic and pharmacokinetic pre-clinical experiments demonstrated superb durability of the long-acting proteins, indicating a potential administration protocol in patients of once per week or up to once every four weeks, pending the specific protein and disease indication. The models were conducted using the industry standard animal models and methods as well as comparative studies to the commercially available versions. Human growth hormone is used to treat growth failure in children and adults, is injected 3-7 times per week, and has an existing estimated market size of $2.2 billion; while interferon beta is prescribed for the treatment of multiple sclerosis, is injected 1-3 times per week, and has an existing estimated market size of $3.8 billion. Neither of these markets currently have a commercial long-acting version available.

In addition, Modigene's long-acting erythropoietin has demonstrated, in a pre-clinical animal model comparative study, increased durability and biological effect over Amgen Inc.'s Aranesp(R), a long-acting erythropoietin with reported sales of $4.1 billion in 2006, out of a total estimated EPO market size of $11.7 billion. Erythropoietin is prescribed for the treatment of anemia.

"We are very excited about Modigene's pre-clinical work to date," said Dr. Phillip Frost, Vice Chairman of Teva Pharmaceutical Industries, and Modigene's largest shareholder and board member. "With four CTP-modified proteins demonstrating to date exceptional results, including Schering-Plough/Organon's FSH-CTP now in Phase III clinical trial, and Modigene's human growth hormone, interferon
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/15/2014)...  Catalist-listed QT Vascular Ltd. ("QT Vascular" or together ... of minimally invasive medical devices for the treatment of ... has enrolled the first European patients in the ENDURE ... have already been enrolled in this study with Dr. ... Auckland, New Zealand . ...
(Date:9/15/2014)... 15, 2014 Research and Markets  has ... 103-90-2) Market Research Report 2014" report to their ... Research Report 2014 presents comprehensive data on paracetamol (acetaminophen) ... Asia , North America ... paracetamol (acetaminophen) description, covers its application areas and related ...
(Date:9/15/2014)... -- MedExpress Urgent Care, a national leader in delivering high-quality and ... ages four and up at each of its 135 centers ... shot early. According to the CDC, all ... late summer and early fall an ideal time to get ... Provider and Clinical Quality, Thomas Pangburn , M.D., suggests ...
Breaking Medicine Technology:First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 2Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 3MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2
... S.C., March 28 Dr. Roger Kenneth,Hershline PhD MD, ... of the not-for-profit public charity CureHIV.us, announces today,that he ... funding from their,Grand Challenges in Global Health initiative. The ... new drug and treatment method, LiSAVIOR., This unique ...
... vector VRX1023 Shows Promising Results, GAITHERSBURG, Md., ... data for VRX1023 today at the Keystone Symposia,Conference ... new vaccine approach --,using HIV-based lentivector as vector ... produced positive results in mice and in,preliminary non-human ...
Cached Medicine Technology:CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR 2VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia 2
(Date:9/16/2014)... September 16, 2014 QuickMedical, a ... and supplies and a veteran-owned small business has ... professionals-- Jant Pharmacal Corporation, Nipro Medical, and CP ... providing its customers the best, most affordable medical ... customers, and in an effort to reach new ...
(Date:9/16/2014)... Cleveland, OH (PRWEB) September 16, 2014 ... of Environmental, Health and Safety (EHS) and Sustainability ... showcasing their newest and most versatile software platform, ... Vegas this October. , MobileWorkflows allow for ... Built on the principles of Responsive Web Design, ...
(Date:9/16/2014)... 2014 True Science Cosmetics, LLC, announces the ... true-ly pampers lips from the inside out with a breakthrough ... “The creation of true lipz™ came about because we, like ... no matter what products we used. We wanted to ... but could actually hydrate and moisturize throughout the day,” said ...
(Date:9/16/2014)... Today, the Diamond in the Raw ... be held, Sunday, October 19, 2014 at the Skirball ... awards show honors the dare-devil stuntwomen of film and ... Over 12 categories will be recognized in the ... , Special honors will be given to legendary ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Banish headaches ... drug-free, FDA approved Cefaly device for chronic migraine relief ... sales in the United States. Until now, US patients ... manufacturer located in Belgium and wait 2-3 weeks for ... in the United States and once prescription and payment ...
Breaking Medicine News(10 mins):Health News:Mobile EHS Compliance Tools the Focus of Dakota Software’s 2014 Users Conference 2Health News:True Science Cosmetics, LLC Launches True Lipz™ 2Health News:Hollywood's Action Icon Awards to Honor Legendary Stuntwomen In A Star-Studded Gala and Awards Ceremony 2Health News:Cefaly Migraine Treatment Device Now Readily Available For Widespread Purchase in United States 2
... , , New line set to hit market in ... -- Jillian Michaels, New York Times bestselling author ... Loser announces her first ever line of weight-loss products in ... at the 2009 National Association of Chain Drug Stores Marketplace in ...
... ... psoriasis medications and the financial help available for those living with the disease ... (Vocus) June 29, 2009 -- ... those with psoriasis . The page is a psoriasis-specific source of help for those ...
... Florida,s First Certified Urgent Care ... Florida has become the first in the State to receive formal recognition as a Certified Urgent ... ... Medical Centers of Palm Beach County Florida has become the first in the State to receive ...
... , ... founder of the alternative health movement, is now a featured expert on searchvitaminsupplements.com, a new ... acids, enzymes, and more. , ... Potomac, MD (Vocus) June 29, 2009 -- Julian Whitaker, MD , a founder of ...
... ... the US Drug Watchdog, "we want to hear from any Zicam Nasal ... smell." The group says, "on June 16, 2009, the U.S. Food and ... remedies because they are associated with the loss of sense of smell ...
... 29 /PRNewswire-Asia/ -- Rising healthcare standards,together with the growing ... for medical tourism buoyant, according to experts speaking at ... Singapore.,Worldwide gross medical tourism revenue is projected to grow ... Asia as a major driver of this,growth. , ...
Cached Medicine News:Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 2Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 3Health News:New Source of Information on Psoriasis Medications 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 3Health News:Dr. Julian Whitaker Featured on Searchvitaminsupplements.com 2Health News:The US Drug Watchdog Expands its Zicam Investigation and Wants to Hear From All Users Who Lost Their Sense of Smell 2Health News:Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012 2Health News:Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012 3
Chembio Diagnostic Systems, Inc.s SURE CHECK HIV 1 / 2, HIV 1/ 2 STAT-PAK and HIV 1/ 2 STAT-PAK Dipstick tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of anti...
... collect sample, pipette into testing wells ... FDA 510K cleared multiple drug screen ... both drugs and adulterants. It can ... (5) drugs and can be accompanied ...
... Pipetting under a hood doesnt need to be ... Portable Pipet-Aid XL has a longer handle to ... perform the same operation as with a conventional ... hand rest and a removable stand which enables ...
... Eclipse,Plus or 850 ECG medical ... capability. Doctors,maintain all the benefits ... and gain the,ability to view ... personal computers., With diagnostic-quality viewing ...
Medicine Products: